Dimethyl Fumarate and Ketamine: What to Monitor
Tecfidera (Dimethyl Fumarate) (also: Vumerity) — Oral disease-modifying therapy for relapsing MS (Nrf2 activator)
Verdict at Tovani Health
Compatible; flushing reaction stacks with ketamine's pressor response.
Dimethyl fumarate and ketamine are compatible. The relevant flag for KAP planning is the flushing reaction — common in the first weeks of therapy, niacin-like, can be uncomfortable, and theoretically stacks with ketamine's transient BP/HR rise. The intrinsic lymphopenia monitoring and PML surveillance are independent of KAP. Vumerity (diroximel fumarate) is a prodrug with better GI tolerability but same overall profile.
If you take Tecfidera regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or modest dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Tecfidera interacts with ketamine
Dimethyl fumarate activates the Nrf2 antioxidant pathway and modulates immune function. Used as oral disease-modifying therapy for relapsing-remitting MS. The flushing is prostaglandin-mediated and dose-related.
What we do at intake
Disclose dose and how long you have been on it. If the flushing reaction is significant, take aspirin 30 min before the dose (standard mitigation) and time sessions outside the flushing window.
Bottom line
Dimethyl fumarate and ketamine are compatible. The relevant flag for KAP planning is the flushing reaction — common in the first weeks of therapy, niacin-like, can be uncomfortable, and theoretically stacks with ketamine's transient BP/HR rise. The intrinsic lymphopenia monitoring and PML surveillance are independent of KAP. Vumerity (diroximel fumarate) is a prodrug with better GI tolerability but same overall profile.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Tecfidera (Dimethyl Fumarate) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources. Rodríguez-Regal A, Ramos-Rúa L, Anibarro-García L. Patient Preference and Adherence. 2021. PMID: 33542621
- Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions. Riva-Posse P, Reiff CM, Edwards JA. Journal of Affective Disorders. 2018. PMID: 29525051
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 19, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.